ATR logo

AptarGroup, Inc. Stock Price

NYSE:ATR Community·US$8.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

ATR Share Price Performance

US$130.59
-28.08 (-17.70%)
40.6% undervalued intrinsic discount
US$220.00
Fair Value
US$130.59
-28.08 (-17.70%)
40.6% undervalued intrinsic discount
US$220.00
Fair Value
Price US$130.59
AnalystHighTarget US$220.00
AnalystConsensusTarget US$177.00
AnalystLowTarget US$153.00

ATR Community Narratives

AnalystHighTarget·
Fair Value US$220 40.6% undervalued intrinsic discount

Rising Global Wellness Trends Will Unlock Biologics And Smart Packaging

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$177 26.2% undervalued intrinsic discount

Advanced Drug Delivery And Sustainable Packaging Will Transform Global Healthcare

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value US$153 14.6% undervalued intrinsic discount

European Destocking And Litigation Will Mar Results But Spur Recovery

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent ATR News & Updates

AptarGroup, Inc.'s (NYSE:ATR) Business Is Trailing The Market But Its Shares Aren't

Aug 28
AptarGroup, Inc.'s (NYSE:ATR) Business Is Trailing The Market But Its Shares Aren't

AptarGroup: Holding Steady Until Q2 Results

Jul 30

AptarGroup's (NYSE:ATR) Dividend Will Be $0.45

Jul 15
AptarGroup's (NYSE:ATR) Dividend Will Be $0.45

Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 28%?

Jul 02
Are Investors Undervaluing AptarGroup, Inc. (NYSE:ATR) By 28%?

These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

Jun 19
These 4 Measures Indicate That AptarGroup (NYSE:ATR) Is Using Debt Reasonably Well

AptarGroup, Inc. Key Details

US$3.6b

Revenue

US$2.2b

Cost of Revenue

US$1.4b

Gross Profit

US$992.1m

Other Expenses

US$391.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
Earnings per share (EPS)
5.94
Gross Margin
38.32%
Net Profit Margin
10.84%
Debt/Equity Ratio
40.4%

AptarGroup, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

1 Risk
4 Rewards

About ATR

Founded
1992
Employees
13500
CEO
Stephan Tanda
WebsiteView website
www.aptar.com

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 1.1%
  • 3 Months: 8.9%
  • 1 Year: 18.9%
  • Year to Date: 15.1%
The market is up 1.1% over the last week, with the Information Technology sector leading the way, up 1.9%. In the last year, the market has climbed 19%. Earnings are forecast to grow by 15% annually. Market details ›